Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
3.390
+0.080 (2.42%)
Aug 24, 2026, 11:50 AM EDT - Market open
Evaxion Market Cap
Evaxion has a market cap or net worth of $28.27 million as of August 24, 2026. Its market cap has increased by 37.72% in one year.
Market Cap
28.27M
Enterprise Value
21.38M
1-Year Change
37.72%
Ranking
Category
Stock Price
$3.39
ChartMarket Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $28.27M, a decrease of -85.27%. That is a compound annual growth rate of -29.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 28.27M | -28.93% |
| Dec 31, 2025 | 39.78M | 702.21% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lantern Pharma | 29.91M |
| Genenta Science | 29.72M |
| BeyondSpring | 29.61M |
| NextCure | 28.79M |
| Tevogen | 28.48M |
| Quantum BioPharma | 28.18M |
| Longeveron | 26.94M |
| Enlivex | 25.70M |